ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,244Medicare Part D Prescriptions Filled, Including Refills

Rank: 116 out of 1206

$529K Total Retail Price of All Prescriptions

Rank: 141 out of 1206

473 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 473 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 473 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 9,376 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 644 558 1 2
SIMVASTATIN 566 471 2 1
WARFARIN SODIUM 450 394 3 8
OMEPRAZOLE 443 344 4 3
AMLODIPINE BESYLATE 393 365 5 6
LISINOPRIL 314 266 6 4
HYDROCHLOROTHIAZIDE 289 280 7 11
METOPROLOL SUCCINATE 273 217 8 15
GABAPENTIN 241 171 9 18
METOPROLOL TARTRATE 231 199 10 9
FUROSEMIDE 229 226 11 5
METFORMIN HCL 219 163 12 10
LOSARTAN POTASSIUM 195 188 13 20
ATORVASTATIN CALCIUM 189 166 14 13
POTASSIUM CHLORIDE 168 160 15 12
TAMSULOSIN HCL 158 142 16 26
TORSEMIDE 140 111 17 144
CITALOPRAM HBR 140 126 17 16
CLOZAPINE 133 0 19 191
DONEPEZIL HCL 119 119 20 29
ALLOPURINOL 119 108 20 24
HYDROCODONE-ACETAMINOPHEN 112 55 S3 22 7
CRESTOR 106 64 23 30
ALENDRONATE SODIUM 105 80 24 19
PREDNISONE 105 94 24 28
FLUOXETINE HCL 98 66 26 52
MIRTAZAPINE 96 82 27 50
ATENOLOL 94 80 28 14
TRAMADOL HCL 92 72 29 17
MELOXICAM 83 64 30 35
BISOPROLOL-HYDROCHLOROTHIAZIDE 83 81 30 108
NEXIUM 82 55 32 47
RANITIDINE HCL 78 32 33 23
NAMENDA 77 76 34 36
VENLAFAXINE HCL ER 77 29 34 89
FENOFIBRATE 75 52 36 56
NOVOLOG 74 29 37 100
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 68 38 27
SYNTHROID 69 47 39 94
AMITRIPTYLINE HCL 69 41 R 39 59
DIGOXIN 67 66 41 43
BENAZEPRIL HCL 67 67 41 39
DIOVAN HCT 67 67 41 112
BYSTOLIC 66 66 44 109
DIOVAN 65 65 45 57
CYMBALTA 60 35 46 63
SERTRALINE HCL 60 46 46 22
CARBAMAZEPINE 59 0 48 146
OXYCODONE-ACETAMINOPHEN 59 41 S2 48 106
CARVEDILOL 58 58 50 32
TRIAMTERENE-HCTZ 58 57 50 33
CLOPIDOGREL 58 39 50 48
DIVALPROEX SODIUM ER 58 18 50 163
LOSARTAN-HYDROCHLOROTHIAZIDE 56 51 54 60
RISPERIDONE 55 26 55 74
MORPHINE SULFATE ER 52 0 S2 56 114
PRIMIDONE 51 0 57 226
LANTUS 50 35 58 38
DILTIAZEM ER 50 42 58 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 14, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.